Sort Through Options for ESBL, CRE, and Resistant Pseudomonas
We're getting questions about how to treat multidrug-resistant (MDR) gram-negative infections.
These infections are often caused by extended-spectrum beta-lactamase (ESBL) producers...carbapenem-resistant Enterobacterales (CRE)...or Pseudomonas with "difficult-to-treat resistance" (DTR).
Be ready to answer questions and work with your ID team.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals